Cargando…

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection

Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunn, Bronwyn M., Bai, Shuangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827636/
https://www.ncbi.nlm.nih.gov/pubmed/34613865
http://dx.doi.org/10.1080/21645515.2021.1976580
_version_ 1784647674846248960
author Gunn, Bronwyn M.
Bai, Shuangyi
author_facet Gunn, Bronwyn M.
Bai, Shuangyi
author_sort Gunn, Bronwyn M.
collection PubMed
description Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also significantly contributes to antiviral protection. Recruitment of innate immune cells such as natural killer cells, neutrophils, monocytes, macrophages, dendritic cells and the complement system by antibodies can lead to direct restriction of viral infection as well as promoting long-term antiviral immunity. Monoclonal antibody therapeutics against viruses are increasingly incorporating Fc-enhancing features to take advantage of the Fc domain, uncovering a surprising breadth of mechanisms through which antibodies can control viral infection. Here, we review the recent advances in our understanding of antibody-mediated innate immune effector functions in protection from viral infection and review the current approaches and challenges to effectively leverage innate immune cells via antibodies.
format Online
Article
Text
id pubmed-8827636
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88276362022-02-10 Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection Gunn, Bronwyn M. Bai, Shuangyi Hum Vaccin Immunother Reviews Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also significantly contributes to antiviral protection. Recruitment of innate immune cells such as natural killer cells, neutrophils, monocytes, macrophages, dendritic cells and the complement system by antibodies can lead to direct restriction of viral infection as well as promoting long-term antiviral immunity. Monoclonal antibody therapeutics against viruses are increasingly incorporating Fc-enhancing features to take advantage of the Fc domain, uncovering a surprising breadth of mechanisms through which antibodies can control viral infection. Here, we review the recent advances in our understanding of antibody-mediated innate immune effector functions in protection from viral infection and review the current approaches and challenges to effectively leverage innate immune cells via antibodies. Taylor & Francis 2021-10-06 /pmc/articles/PMC8827636/ /pubmed/34613865 http://dx.doi.org/10.1080/21645515.2021.1976580 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Reviews
Gunn, Bronwyn M.
Bai, Shuangyi
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title_full Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title_fullStr Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title_full_unstemmed Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title_short Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
title_sort building a better antibody through the fc: advances and challenges in harnessing antibody fc effector functions for antiviral protection
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827636/
https://www.ncbi.nlm.nih.gov/pubmed/34613865
http://dx.doi.org/10.1080/21645515.2021.1976580
work_keys_str_mv AT gunnbronwynm buildingabetterantibodythroughthefcadvancesandchallengesinharnessingantibodyfceffectorfunctionsforantiviralprotection
AT baishuangyi buildingabetterantibodythroughthefcadvancesandchallengesinharnessingantibodyfceffectorfunctionsforantiviralprotection